EyePoint, Inc. layoffs
Yes. EyePoint, Inc. has filed 2 SEC 8-Ks with Item 2.05 (exit or disposal costs) since 2023. The most recent, on Oct 19, 2026, described a cut of about 53% of its workforce.
Check EYPT layoff riskSEC filings since 2023
- Oct 192026
EyePoint cutting about 53% of its workforce
EyePoint, Inc. (EYPT) · filed 3 weeks agoOn October 17, 2026, following review of topline results from LUCIA, the second pivotal Phase 3 clinical trial evaluating DURAVYU for the treatment of wet age-related macular degeneration (wet AMD), the Board of Directors of the Company approved a strategic prioritization plan (the "Prioritization") designed to reduce operating expenses and focus resources on the Company’s late-stage program for DURAVYU in diabetic macular edema (DME).
- May 182023
EyePoint Pharmaceuticals to cut about 35 jobs
EyePoint Pharmaceuticals, Inc. (EYPT) · filed 182 weeks agoOn May 17, 2023, the Board of Directors of the Company (the “ Board ”) committed to a course of action to terminate approximately 35 employees, consisting of the Company’s sales and marketing organization and other supporting roles (the “ RIF ”).
Get this data via API
Pull layoff filings, risk scores, and WARN notices into your own product. Starts at $49/mo.